BR0212287A - Proteìna de ligação caspase-8, sua preparação e uso - Google Patents

Proteìna de ligação caspase-8, sua preparação e uso

Info

Publication number
BR0212287A
BR0212287A BR0212287-1A BR0212287A BR0212287A BR 0212287 A BR0212287 A BR 0212287A BR 0212287 A BR0212287 A BR 0212287A BR 0212287 A BR0212287 A BR 0212287A
Authority
BR
Brazil
Prior art keywords
caspase
preparation
binding protein
cari
methods
Prior art date
Application number
BR0212287-1A
Other languages
English (en)
Inventor
David Wallach
Tanya Goncharov
Ganesh Kolumam
Akhil Rajput
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14527801A external-priority patent/IL145278A0/xx
Priority claimed from IL14625101A external-priority patent/IL146251A0/xx
Priority claimed from IL14748702A external-priority patent/IL147487A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of BR0212287A publication Critical patent/BR0212287A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)

Abstract

"PROTEìNA DE LIGAçãO CASPASE-8, SUA PREPARAçãO E USO". A presente invenção refere-se a um polipeptídeo de interação da caspase-8 (Cari), métodos para sua preparação e seu uso.
BR0212287-1A 2001-09-04 2002-09-04 Proteìna de ligação caspase-8, sua preparação e uso BR0212287A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL14527801A IL145278A0 (en) 2001-09-04 2001-09-04 A caspase-8 binding protein, its preparation and use
IL14625101A IL146251A0 (en) 2001-09-04 2001-10-31 A caspase-8 binding protein, its preparation and use
IL14748702A IL147487A0 (en) 2002-01-06 2002-01-06 A caspase-8 binding protein, its preparation and use
PCT/IL2002/000733 WO2003020759A2 (en) 2001-09-04 2002-09-04 A caspase- 8 binding protein, its preparation and use

Publications (1)

Publication Number Publication Date
BR0212287A true BR0212287A (pt) 2004-09-14

Family

ID=27271952

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212287-1A BR0212287A (pt) 2001-09-04 2002-09-04 Proteìna de ligação caspase-8, sua preparação e uso

Country Status (10)

Country Link
US (2) US7354736B2 (pt)
EP (1) EP1423422A2 (pt)
JP (1) JP2005501545A (pt)
KR (1) KR20040049845A (pt)
CN (1) CN1630664A (pt)
BR (1) BR0212287A (pt)
CA (1) CA2459136A1 (pt)
EA (1) EA009956B1 (pt)
MX (1) MXPA04002103A (pt)
WO (1) WO2003020759A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE478559T1 (de) 2006-05-03 2010-09-15 Univ California Nachweis von protease und protease-aktivität mithilfe einer einzel-nanosteigerungs-sers-sonde
AU2007264672B2 (en) * 2006-06-28 2013-03-14 Hadasit Medical Research Services & Development Ltd Caspase-8 and inflammation, infection and wound healing
US8150192B2 (en) * 2006-11-27 2012-04-03 Merge Cad Inc. System and method for feature score mapping and visualization of medical images
US8778302B2 (en) * 2007-03-09 2014-07-15 The University Of British Columbia Procaspase 8-mediated disease targeting
KR101682730B1 (ko) 2008-10-08 2016-12-05 캠브리지 엔터프라이즈 리미티드 다발경화증에 대한 2차 자가면역 질환의 진단 및 치료를 위한 방법 및 조성물
EP2855666B1 (en) 2012-05-25 2019-12-04 Cellectis Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
AU2013312838B2 (en) * 2012-09-04 2018-11-29 Cellectis Multi-chain chimeric antigen receptor and uses thereof
RU2671510C1 (ru) * 2016-06-29 2018-11-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ выделения белкового высокомолекулярного комплекса активации каспазы-2 человека
WO2018068022A1 (en) 2016-10-06 2018-04-12 Poseida Therapeutics, Inc. Inducible caspases and methods for use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2276085A1 (en) * 1997-01-09 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
US20040101927A9 (en) * 2000-01-31 2004-05-27 Rosen Craig A. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
JP2005501545A (ja) 2005-01-20
US20050048639A1 (en) 2005-03-03
EP1423422A2 (en) 2004-06-02
EA009956B1 (ru) 2008-04-28
CN1630664A (zh) 2005-06-22
US20080254028A1 (en) 2008-10-16
EA200400392A1 (ru) 2004-10-28
US7354736B2 (en) 2008-04-08
KR20040049845A (ko) 2004-06-12
WO2003020759A9 (en) 2003-12-31
WO2003020759A2 (en) 2003-03-13
MXPA04002103A (es) 2004-06-07
WO2003020759A3 (en) 2003-11-27
CA2459136A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
BR0212256A (pt) Proteìnas de fusão de transferrina modificadas
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
AU623779B2 (en) New porus pharmaceutical form and its preparation
BR0212287A (pt) Proteìna de ligação caspase-8, sua preparação e uso
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
AU2002233424A1 (en) Peptides having affinity for the GP120 viral protein and use thereof
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
NO995062L (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som koder for samme
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
NO932823L (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og konjugater, for anvendelse som kontrastmidler og fremgangsmåter for deres fremstilling
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
MXPA04002104A (es) Anticuerpos contra caspasa-8, su preparacion y uso.
AU2001241880A1 (en) 2504, 15977, and 14760, novel protein kinase family members and uses therefor
AU2002248190A1 (en) Method of complexing a protein by the use of a dispersed system and proteins thereof
AU2002326343A1 (en) 87144, human amino acid transporter family member and uses therefor
Lee Binding motif analysis of proacrosin and the proacrosin binding protein
AU6891301A (en) A novel polypeptide, a human protein phosphatase 4 regulatory subunit 37 and thepolynucleotide encoding the polypeptide
AU8948301A (en) A novel polypeptide, a human splicing protein 10.56 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.